Powder: | Yes |
---|---|
Customized: | Customized |
Certification: | GMP, HSE, ISO 9001, USP, BP |
Suitable for: | Elderly, Children, Adult |
State: | Powder |
Purity: | >99% |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Items | Specifications | Results |
Appearance | White to off-White powder | Off-White powder |
Identification | H-NMR, MS | Complies |
Water(by KF) | 2.5~5.0% | 4.5% |
Residue on ignition | £0.1% | 0.05% |
Heavy metals | £20ppm | Complies |
Content of chloride | 5.7%~6.9% | 6.4% |
Crystal form | There should be characteristic peaks at 7.29±0.02°,9.28±0.02°,11.49±0.02°,12.07±0.02°,19.99± 0.02°,22.03±0.02°,24.00±0.02°,25.12±0.02°,26.03±0.02 °,and The XRD spectrum of the sample correspond to that of crystal form B | Complies |
Residual solvents | Dichloromethane≤0.06% | ND |
methanol≤0.3% | 0.01% | |
Ethyl acetate≤0.5% | 0.01% | |
Toluene≤0.089% | ND | |
Acetone≤0.5% | ND | |
Related substances (HPLC) | 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)ani line≤0.1% | ND |
4-Methyl-3-(4-(pyridine-3-yl)pyrimidin-2-ylamino)be nzoic acid≤0.1% |
0.01% | |
4-Methyl-1-(3-nitro-5-trifluoromethyl-phenyl)-1H-im idazole≤0.1% |
ND | |
Related Impurity by HPLC | Total impurity ≤1.0% Single impurity ≤0.15% |
0.04% 0.02% |
Purity(HPLC) | ³99.5% | 99.96% |
Abaloparatide | octenidine dihydrochloride | ABT-263 |
Abemaciclib | O-Desmethylgefitinib | ABT-737 |
Abiraterone | Osimertinib Mesylate | AZD0328 |
acalabrutinib | Pacritinib | AZD1236 |
ALTIRATINIB | Pazopanib HCL | AZD-1480 |
amfonelic acid | Peficitinib | AZD1656 |
Anlotinib | Pegdinetanib | AZD1775 |
Asciminib | ponatinib | AZD1981 |
Atipamezole HCl | Pyrotinib | AZD2014 |
Atuveciclib | R788(FOSTAMATINIB DISODIUM) | AZD4017 |
AV-951 | Radotinib | AZD4573 |
Avapritinib | ramelteon | AZD5069 |
Axitinib | Refametinib | AZD5153 |
Bafetinib | Ribociclib | AZD5213 |
bendamustine hydrochloride | Riviciclib hydrochloride | AZD5904 |
Binimetinib | ruxolitinib | AZD7325 |
Bosutinib | Saracatinib | AZD9150 |
brigatinib | Savolitinib | Batimastat |
Cabozantinib | Semaxanib | BMS202 |
Cabozantinib Maleate | Simotinib HCl | BMS-214662 |
Capmatinib | Solcitinib | Carfilzomib |
Cediranib | Sonolisib | CEP-40783 |
Cerdulatinib | Sulfatinib | CO-1686 |
Chiauranib | sunitinib | darolutamide |
Cinchocaine HCL | Sunitinib Maleate | EDO-S101 |
Cipatinib | Teniposide | emodepside |
Cobimetinib | Toceranib | EPZ-6438 |
Dacomitinib | Tofacitinib citrate | IPI-145 |
dasatinib | trametinib | LDE225 HCL |
Decernotinib | Vandetanib | MK2206 |
Donafenib | Volitinib | OSI-027 |
dovitinib | Voruciclib hydrochloride | OTSSP167 |
E7449 | WORTMANNIN | PD 98059 |
Entospletinib | Zibotentan(ZD4054) | PF-04691502 |
Erdafitinib | zuclopenthixol | PI-103 |
Erlotinib | larotrectinib | PLX3397 |
etoposide | Lerociclib dihydrochloride | PLX4720 |
Famitinib | Lesogaberan AZD3355 | PP-121 |
Filgotinib | levatinib | PQR309/Bimiralisib |
Firocoxib | Lorlatinib | Sapanisertib |
Flumatinib | Maraviroc | selinexor |
Foretinib | Masitinib mesylate | S-Ruxolitinib |
Fostamatinib | Mocetinostat | TAE684 |
Fruquintinib | neratinib | Tafamidis |
Gefitinib | tenapanor | |
Gilteritinib | Verteporfin | |
Golvatinib | WYE-354 | |
Henatinib | WYE-687 | Atezolizumab |
Icotinib | 4-IPP | Avelumab |
imatinib | A-770041 | Durvalumab |
imatinib mesylate | MLN4924 | Pembrolizumab |
Lapatinib | OTX-015 | Pertuzumab |
lapatinib ditosylate | PLX3397 Pexidartinib | Ramucirumab |
Midostaurin | WAY-600 | |
nilotinib | WEHI-539 | |
Oclacitinib maleate | WYE-125132 |
Shipping Terms | ||
By Express | By Air | By Sea |
Suitable for under 50kg Fast:3-4 days High cost Door to door service Easy to pick up the goods |
Suitable for more than 50kg Fast:3-4 days High cost Airport to airport Professional broker needed |
Suitable for more than 500kg Slow:15-30 days Low cost Port to port Professional broker needed |
Suppliers with verified business licenses